Insights From the informCLL Registry: Real-World Application of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

被引：0
|
作者：
Ghosh, Nilanjan [1 ]
Brander, Danielle [2 ]
Mato, Anthony R. [3 ]
Sharman, Jeff P. [4 ]
Gutierrez, Meghan [5 ]
Naganuma, Maoko [6 ]
Upasani, Sandhya [6 ]
Alagappan, Divi [7 ]
Huang, Qing [7 ]
Young, Alex [6 ]
Barrientos, Jacqueline C. [8 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[2] Duke Univ Hlth Syst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Willamette Valley Canc Inst & Res Ctr, US Oncol Res, Eugene, OR USA
[5] Lymphoma Res Fdn, New York, NY USA
[6] Pharmacyclics LLC, Sunnyvale, CA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Donald Barbara Zucker Sch Med Hofstra Northwell, Div Med Oncol & Hematol, Northwell Hlth Canc Inst, Lake Success, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
CLL; CLL/SLL; real-world; registry; del(17p); TP53;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-074
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [21] Clinical Practice Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia (CLL) in The Netherlands
    Kersting, Sabina
    Neppelenbroek, Suzanne I. M.
    Visser, Hein P. J.
    van Gelder, Michel
    Levin, Mark-David
    Mous, Rogier
    Posthuma, Ward
    van der Straaten, Hanneke M.
    Kater, Arnon P.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 52 - 57
  • [22] Treatment and prognostic testing patterns in patients with chronic lymphocytic leukemia: updates from the informCLL™ real-world registry
    Ghosh, Nilanjan
    Mato, Anthony
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Upasani, Sandhya
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 31 - 33
  • [23] Real-world Bruton tyrosine kinase inhibitor (BTKi) treatment patterns and outcomes among patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) in US community oncology practices
    Hou, Jing-Zhou
    Blanc, Simon
    Maglinte, Gregory A.
    Vasudevan, Anupama
    Rui, Anna
    Gart, Mike
    Pham, Hoa
    Aton, Lindsay
    Wang, Brandon
    Choksi, Rushir J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Real-world duration of venetoclax treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma
    Teschemaker, Anna
    Hakre, Shweta
    Tse, Jenny
    Shaikh, Nazneen Fatima
    Gu, Yifan
    Near, Aimee
    LEUKEMIA & LYMPHOMA, 2023, 64 : S62 - S63
  • [25] A Real-World Study of Zanubrutinib Treatment in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Zhu, Huayuan
    Xia, Yi
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Qiu, Tonglu
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jianyong
    BLOOD, 2023, 142
  • [26] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.
    Rogers, Kerry Anne
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] REAL-WORLD ECONOMIC OUTCOMES OF FIRST-LINE (1L) IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL)
    Challagulla, S.
    Lee, P.
    Kistler, K.
    Douyon, L.
    Lai, D.
    Iyengar, R.
    VALUE IN HEALTH, 2021, 24 : S38 - S38
  • [28] Prognostic Testing and Treatment Approaches in Patients with Chronic Lymphocytic Leukemia: Clinical Experience from an Interim Analysis of the informCLL™ Real-World Registry
    Mato, Anthony R.
    Barrientos, Jacqueline C.
    Brander, Danielle M.
    Pagel, John M.
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ghosh, Nilanjan
    Giafis, Nick
    Ipe, David
    Upasani, Sandhya
    Sundaram, Murali
    Ferrante, Lucille
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    BLOOD, 2018, 132
  • [29] Real-world evidence study of treatment patterns and outcomes following covalent BTKi discontinuation in a contemporary cohort of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients
    Lin, Kevin H.
    Huynh, Lynn
    Yang, Xiaoqin
    Zanardo, Enrico
    Lema, Neema
    Matay, Lisa
    Balasubramanian, Sobana
    Liborski, Daria
    McDonough, Mikaela
    Foreman, Jillian
    Farooqui, Mohammed Z. H.
    De Nigris, Enrico
    Gandra, Shravanthi R.
    Sarpong, Eric M.
    Duh, Mei Sheng
    Brown, Jennifer R.
    Davids, Matthew Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Real-world outcomes following adverse events and dose reduction of first-line ibrutinib in Medicare beneficiaries with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shadman, Mazyar
    Srivastava, Bhavini P.
    Salkar, Monika
    Saifan, Chadi
    Agatep, Barnabie C.
    Jones, Barton
    Ryan, Olga
    Bacchus, Shaffee
    Stephens, Deborah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345